doc. MUDr. Petr Szturz, Ph.D.


e‑mail:
Životopis

Curriculum vitae

Department/Faculty/University
  • Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Masaryk University, School of Medicine
Function, current position
  • Medical Oncology Specialist (Division of Solid Tumor Oncology), Associate Professor
Education and academic qualifications
  • 2016: Associate Professor of Oncology
  • 2015: ESMO Examination in Medical Oncology
  • 2009-2014: Specialty Training in Medical Oncology
  • 2010-2012: Ph.D. in Oncology
    Thesis: "New diagnostic and therapeutic methods in selected rare hematooncological diagnoses"
  • 2003-2009: M.D. in General Medicine (passed with honours)
Professional experience
  • Since 2010: Lecturer
    Masaryk University, School of Medicine
  • Since 2009: Physician
    Department of Internal Medicine, Hematology and Oncology, University Hospital Brno
Teaching activities
  • Internal Medicine, Oncology
Academic activities
  • 90 scientific publications (of which 41 as the first author)
  • 57 cumulative impact factor
  • 175 citations
  • Projects:
    Evaluation of MET Expression and Inhibition in Squamous Cell Carcinomas of the Head and Neck (ESMO)
    Register of Very Rare Hematooncologic Diseases in Adult Patients (SUp FNB 2/14)
    Internet Portal for Very Rare Hematologic and Oncologic Diseases (23/14/NAP)
Internship and stays for the purpose of study or work
  • 2015-2016: ESMO Translational Research Fellowship at the Bichat-Beaujon University Hospital in Paris, France
  • 2014: ESMO Clinical Unit Visit fellowship at the Antwerp University Hospital in Belgium
  • 2007-2008: Medical University of Vienna and the Vienna General Hospital, Austria under the Socrates/Erasmus programme
  • 2007: Kliniken Erlabrunn in Germany (surgery, internal medicine)
Research interests
  • Head & Neck Cancer
  • Translational Research
  • Very Rare Diseases - Histiocytic disorders, Castleman disease, Skin manifestations of monoclonal gammopathies, Vasculopathies
Professional Society Memberships
  • European Society for Medical Oncology
  • Czech Society of Internal Medicine
  • Czech Society for Oncology
  • Czech Society of Hematology
Awards Related to Science and Research
  • 2013: Young Investigators' Award during the DGHO 2013 Congress in Vienna
  • 2013: 1st place for the best original article in 2012 from the Czech Society of Internal Medicine
  • 2011: Paul Janssen Award for the most outstanding publication contribution to multiple myeloma
Peer-reviewed journals with IF (first or corresponding author):
  • SZTURZ, Petr, E. RAYMOND a S. FAIVRE. c-MET-mediated resistance to EGFR inhibitors in head and neck cancer: How to move from bench to bedside. Oral oncology, AMSTERDAM: ELSEVIER SCIENCE BV, 2016, roč. 59, AUG 2016, s. "E12"-"E14". ISSN 1368-8375. doi:10.1016/j.oraloncology.2016.05.017. URL info
  • SZTURZ, Petr, Pol SPECENIER, Carl VAN LAER, Danielle VAN DEN WEYNGAERT, Bob CORTHOUTS, Laurens CARP, Eric VAN MARCK, Olivier VANDERVEKEN a Jan B. VERMORKEN. Long-term remission of locally recurrent oropharyngeal cancer after docetaxel-based chemotherapy plus cetuximab. European Archives of Oto-Rhino-Laryngology and Head & Neck, NEW YORK: SPRINGER, 2016, roč. 273, č. 6, s. 1629-1636. ISSN 0937-4477. doi:10.1007/s00405-015-3673-y. info
  • SZTURZ, Petr a S. FAIVRE. Letter to the editor referring to the publication entitled “The role of antagonists of the PD-1:PD-L1/PD-L2 axis in head and neck cancer treatment” by Pai et al. Oral Oncology, Amsterdam: Elsevier Science BV, 2016, roč. 62, "neuvedeno", s. "e3"-"e4". ISSN 1368-8375. doi:10.1016/j.oraloncology.2016.08.007. info
  • ŘEHÁK, Zdeněk a Petr SZTURZ. Comment on: FDG PET in the early diagnosis of large-vessel vasculitis. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, SPRINGER, 2014, roč. 41, č. 3, s. 579-580. ISSN 1619-7070. doi:10.1007/s00259-013-2662-x. info
  • ŘEHÁK, Zdeněk, Petr SZTURZ, Leoš KŘEN, Zdeněk FOJTÍK a Jaroslav STANÍČEK. Upsampling from aorta and aortic branches: PET/CT hybrid imaging identified 18F-FDG hypermetabolism in inflamed temporal and occipital arteries. CLINICAL NUCLEAR MEDICINE, PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS, 2014, roč. 39, č. 1, s. "e84"-"e86". ISSN 0363-9762. doi:10.1097/RLU.0b013e3182868aae. info
  • SZTURZ, Petr. Very rare diseases in oncology. Medical oncology, Totowa: HUMANA PRESS INC, 2014, roč. 31, č. 5, s. 947-948. ISSN 1357-0560. doi:10.1007/s12032-014-0947-y. info
  • SZTURZ, Petr, Zdeněk ADAM, Z. ŘEHÁK a Renata KOUKALOVÁ. Xanthelasma palpebrarum responding to interleukin-1 blockade. Internal medicine journal, Hoboken: Wiley-Blackwell, 2014, roč. 44, č. 6, s. 617-618. ISSN 1444-0903. doi:10.1111/imj.12441. info
  • SZTURZ, Petr, M. PRÁŠEK, Z. ŘEHÁK a P. FABIAN. Unicentric Castleman disease: from screening mammography to PET/CT imaging. Nuklearmedizin-Nuclear Medicine, Stuttgart: Schattauer GmbH-Verlag Medizin Naturwissenschaften, 2014, roč. 53, č. 5, s. "N41"-"N43". ISSN 0029-5566. info
  • SZTURZ, Petr, Zdeněk ADAM, Vladimír VAŠKŮ, Josef FEIT, Marta KREJČÍ, Luděk POUR, Roman HÁJEK a Jiří MAYER. Complete remission of multiple myeloma associated scleredema after bortezomib-based treatment. LEUKEMIA & LYMPHOMA, LONDON: INFORMA HEALTHCARE, 2013, roč. 54, č. 6, s. 1324-1326. ISSN 1042-8194. doi:10.3109/10428194.2012.738816. info
  • SZTURZ, Petr, Libor HLAVATÝ, Jiří PRÁŠEK a Dana DVOŘÁKOVÁ. Erdheim-Chester disease and Schnitzler syndrome: so near, and yet so far. USA: Springer, 2013. doi:10.1007/s12185-013-1437-2. info
  • ADAM, Zdeněk, Petr SZTURZ, Jiří VANÍČEK, Mojmír MOULIS, Luděk POUR, Marta KREJČÍ, Roman HÁJEK a Jiří MAYER. Cladribine (2-chlorodeoxyadenosine) in frontline chemotherapy for adult Langerhans cell histiocytosis: A single-center study of seven cases. Acta Oncologica, LONDON: INFORMA HEALTHCARE, 2013, roč. 52, č. 5, s. 994-1001. ISSN 0284-186X. doi:10.3109/0284186X.2012.716164. info
  • SZTURZ, Petr, Zdeněk ADAM, Zdenek REHAK, Renata KOUKALOVÁ, Leoš KŘEN, Mojmír MOULIS, Marta KREJČÍ a Jiří MAYER. Salvage lenalidomide in four rare oncological diseases. Tumori, Roma: PENSIERO SCIENTIFICO EDITOR, 2013, roč. 99, č. 5, s. "e251"-"e256". ISSN 0300-8916. doi:10.1700/1377.15326. URL info
  • SZTURZ, Petr, Zdeněk ADAM, Zdeněk ŘEHÁK, Renata KOUKALOVÁ, Radka ŠLAISOVÁ, Olga STEHLÍKOVÁ, Jana CHOVANCOVÁ, Martin KLABUSAY, Marta KREJČÍ, Luděk POUR, Roman HÁJEK a Jiří MAYER. Lenalidomide proved effective in multisystem Langerhans cell histiocytosis. Acta Oncologica, 2012, roč. 51, č. 3, s. 412-415. ISSN 0284-186X. doi:10.3109/0284186X.2011.631581. info
  • SZTURZ, Petr, Zdeněk ŘEHÁK, Renata KOUKALOVÁ, Zdeněk ADAM, Marta KREJČÍ, Luděk POUR, Lenka ZAHRADOVÁ, Jiří VANÍČEK, Tomáš NEBESKÝ, Roman HÁJEK a Jiří MAYER. Measuring diffuse metabolic activity on FDG-PET/CT: new method for evaluating Langerhans cell histiocytosis activity in pulmonary parenchyma. Nuclear Medicine and Biology, 2012, roč. 39, č. 3, s. 429-436. ISSN 0969-8051. doi:10.1016/j.nucmedbio.2011.10.002. info
  • ŘEHÁK, Zdeněk, Petr SZTURZ, Eva KREJČÍ a Ilona KOCÁKOVÁ. FDG-PET-Positive Foreign-Body Granuloma Mimicking Residual Germinal Tumor Infiltration. Clinical Nuclear Medicine, 2012, roč. 37, č. 8, s. 790-792. ISSN 0363-9762. doi:10.1097/RLU.0b013e3182485291. info
  • SZTURZ, Petr, Zdeněk ADAM, Jana CHOVANCOVÁ, Olga STEHLÍKOVÁ, Martin KLABUSAY, Josef FEIT, Leoš KŘEN, Zdeněk FOJTÍK, Marta KREJČÍ, Luděk POUR, Roman HÁJEK a Jiří MAYER. Cytokine analysis in a patient with relapsing Kikuchi-Fujimoto disease. Leukemia & Lymphoma, LONDON: INFORMA HEALTHCARE, 2012, roč. 53, č. 4, s. 743-745. ISSN 1042-8194. doi:10.3109/10428194.2011.627482. info
  • SZTURZ, Petr, Zdeněk ADAM, Jana CHOVANCOVÁ, Olga STEHLÍKOVÁ, Martin KLABUSAY, Z. ŘEHÁK, R. KOUKALOVÁ, Lenka ZAHRADOVÁ, Marta KREJČÍ, Luděk POUR, Roman HÁJEK a Jiří MAYER. Lenalidomide: a new treatment option for Castleman disease. Leukemia & Lymphoma, LONDON: INFORMA HEALTHCARE, 2012, roč. 53, č. 10, s. 2089-2091. ISSN 1042-8194. doi:10.3109/10428194.2011.621564. info
  • SZTURZ, Petr, Zdeněk ADAM, Roman HÁJEK a Jiří MAYER. Successful Anakinra Therapy in 2 Patients with Schnitzler Syndrome. Onkologie, Switzerland: Karger, 2011, roč. 34, č. 5, s. 265-268. ISSN 0378-584X. doi:10.1159/000327816. URL info
  • SZTURZ, Petr, Zdeněk ADAM, Mária KLINCOVÁ, Josef FEIT, Marta KREJČÍ, Luděk POUR, Lenka ZAHRADOVÁ, Vladimír VAŠKŮ, Roman HÁJEK a Jiří MAYER. Multiple Myeloma Associated IgA Pemphigus: Treatment With Bortezomib- and Lenalidomide-Based Regimen. Clinical Lymphoma, Myeloma & Leukemia, 2011, roč. 11, č. 6, s. 517-520. ISSN 2152-2650. doi:10.1016/j.clml.2011.06.014. info

2016/09/04